Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: J Affect Disord. 2020 Sep 23;278:542–555. doi: 10.1016/j.jad.2020.09.071

Table 3.

Time-course analysis of outcomes

Outcome Random effects model z p-value I2 k
4–12 hours
Suicidality SMD = −0.7045 [−1.2148; −0.1942] −2.71 0.0068 82.9 9
24 hours
Response RR = 2.6011 [1.8599; 3.6378] 5.59 < 0.0001 61.0 28
Remission RR = 3.2823 [2.0966; 5.1385] 5.20 < 0.0001 8.7 14
Score SMD = −1.0636 [−1.3926; −0.7346] −6.34 < 0.0001 89.3 28
Suicidality SMD = −0.6876 [−1.1461; −0.2291] −2.94 0.0033 81.2 9
48 hours
Response RR = 1.4124 [1.0217; 1.9524] 2.09 0.0366 57.2 12
Score SMD = −1.0474 [−1.5189; −0.5759] −4.36 < 0.0001 79.5 12
72 hours
Response RR = 2.1836 [1.4397; 3.3120] 3.67 0.0002 68.5 18
Remission RR = 2.3576 [1.1980; 4.6396] 2.48 0.0130 51.0 8
Score SMD = −0.8763 [−1.2076; −0.5450] −5.18 < 0.0001 75.4 18
Suicidality SMD = −0.9243 [−1.5804; −0.2683] −2.76 0.0058 79.9 5
One week
Response RR = 1.8660 [1.3805; 2.5220] 4.06 < 0.0001 56.5 25
Remission RR = 2.5868 [1.2728; 5.2574] 2.63 0.0086 50.2 11
Score SMD = −1.0179 [−1.3615; −0.6743] −5.81 < 0.0001 89.6 24
Suicidality SMD = −0.4287 [−0.8202; −0.0373] −2.15 0.0318 67.6 8
Two weeks
Response RR = 1.5796 [1.1926; 2.0921] 3.19 < 0.0001 50.2 15
Remission RR = 7.5979 [2.8489; 20.2632] 4.05 < 0.0001 0.0 5
Score SMD = −0.6418 [−0.9020; −0.3817] −4.84 < 0.0001 75.8 15
Suicidality SMD = −0.2506 [−0.5182; 0.0170] −1.84 0.0665 0.0 5
Three weeks
Response RR = 5.4566 [2.7713; 10.7437] 4.91 < 0.0001 70.2 7
Remission RR = 4.9525 [1.0471; 23.4241] 2.02 0.0436 10.2 2
Score SMD = −0.2618 [−0.3908; −0.1328] −3.96 < 0.0001 0.0 7
Four weeks
Response RR = 1.3891 [1.1655; 1.6557] 3.67 0.0002 27.8 7
Remission RR = 1.5309 [1.2056; 1.9438] 3.49 0.0005 25.2 7
Score SMD = −0.3037 [−0.4346; −0.1728] −4.55 < 0.0001 0.0 6
Suicidality SMD = −0.1602 [−0.4472; 0.1268] −1.09 0.2741 0.0 4

RR = rate ratio; SMD = standardized mean difference; z = z-score (on normal distribution); I2 = measure of heterogeneity (closer to 100.0 indicates higher heterogeneity); k = number of trials involved in the sub analysis